Magro F, Fraga S, Ribeiro T, Soares-da-Silva P
Institute of Pharmacology and Therapeutics, Faculty of Medicine, Porto, Portugal.
Acta Physiol Scand. 2005 Feb;183(2):191-9. doi: 10.1111/j.1365-201X.2004.01388.x.
This study evaluated Na+,K+-ATPase activity and the abundance of alpha1 subunit Na+,K+-ATPase in experimental colitis and gathered evidence on the effects of interferon-gamma (IFN-gamma) on intestinal Na+,K+-ATPase.
Colitis was induced by the intrarectal administration of 2,4,6-trinitrobenzene sulphonic acid (TNBS, 30 mg/250 microL). Na+,K+-ATPase activity was determined as the difference between total and ouabain-insensitive ATPase. The abundance of Na+,K+-ATPase was analysed by immunoblotting.
Na+,K+-ATPase activity was markedly reduced in the proximal colonic mucosa of TNBS-treated rats, whereas upstream in the terminal ileal mucosa a marked increase in sodium pump activity was observed. At the jejunal level no significant changes in Na+,K+-ATPase activity were observed between TNBS-treated rats and corresponding controls (ethanol-treated rats). No changes were observed in the abundance of alpha1 subunit Na+,K+-ATPase in the proximal colon, terminal ileum and jejunum. The administration of IFN-gamma (50,000 U) 48 h before sacrifice reduced both Na+,K+-ATPase activity and the abundance of alpha1 subunit Na+,K+-ATPase in the proximal colon. Dexamethasone prevented colonic inflammation and decreases in proximal colonic Na+,K+-ATPase activity in TNBS-treated rats, but did not affect the INF-gamma-induced decrease in colonic Na+,K+-ATPase activity.
The increase in ileal Na+,K+-ATPase activity upstream to the lesioned colonic mucosa, where Na+,K+-ATPase activity was markedly reduced, might indicate a compensatory process to counteract the decrease in water and electrolyte absorption at the colonic level. This decrease in colonic Na+,K+-ATPase activity is likely not related to INF-gamma-induced downregulation of Na+,K+-ATPase.
本研究评估了实验性结肠炎中钠钾ATP酶(Na +,K + -ATPase)的活性以及α1亚基钠钾ATP酶的丰度,并收集了关于γ干扰素(IFN-γ)对肠道钠钾ATP酶影响的证据。
通过直肠内注射2,4,6-三硝基苯磺酸(TNBS,30mg/250μL)诱导结肠炎。钠钾ATP酶活性通过总ATP酶与哇巴因不敏感ATP酶之间的差异来测定。通过免疫印迹分析钠钾ATP酶的丰度。
TNBS处理的大鼠近端结肠黏膜中钠钾ATP酶活性显著降低,而在回肠末端黏膜的上游观察到钠泵活性显著增加。在空肠水平,TNBS处理的大鼠与相应对照组(乙醇处理的大鼠)之间钠钾ATP酶活性未观察到显著变化。近端结肠、回肠末端和空肠中α1亚基钠钾ATP酶的丰度未观察到变化。在处死前48小时给予IFN-γ(50,000U)可降低近端结肠中钠钾ATP酶活性以及α1亚基钠钾ATP酶的丰度。地塞米松可预防TNBS处理的大鼠结肠炎症和近端结肠钠钾ATP酶活性降低,但不影响IFN-γ诱导的结肠钠钾ATP酶活性降低。
在病变结肠黏膜上游的回肠钠钾ATP酶活性增加,而结肠黏膜中钠钾ATP酶活性显著降低,这可能表明是一种补偿过程,以抵消结肠水平水和电解质吸收的减少。结肠钠钾ATP酶活性的降低可能与IFN-γ诱导的钠钾ATP酶下调无关。